Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure-Reference-Cited by-同舟云学术

Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure

Published:2024-02-01 Issue:3 Volume:63 Page:399-402
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Funaki Takashi¹,Saji Mike¹,Terada Mai¹,Takamisawa Itaru¹,Nanasato Mamoru¹,Nagao Takehiko²,Ikeda Takanori³,Isobe Mitsuaki⁴

Affiliation:

1. Department of Cardiology, Sakakibara Heart Institute, Japan

2. Department of Neurology, Nippon Medical School Musashikosugi Hospital, Japan

3. Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Japan

4. Sakakibara Heart Institute, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/63/3/63_1778-23/_pdf

Reference11 articles.

1. 1. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. JACC 58: e212-e260, 2011.

2. 2. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35: 2733-2779, 2014.

3. 3. Herzog CA, Asinger RW, Berger AK. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80: 572-586, 2011.

4. 4. Reddy VY, Doshi SK, Kar S, et al.; PREVAIL and PROTECT AF Investigators. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. JACC 70: 2964-2975, 2017.

5. 5. Mo BF, Zhang R, Yuan JL, et al. Left atrial appendage closure for primary and secondary stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: a pilot study. Front Cardiovasc Med 13: 719-755, 2021.